| RS866686536 |
DRD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary attention deficit-hyperactivity disorder, Hereditary attention deficit-hyperactivity disorder |
| RS866688232 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS866689896 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS866703165 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS866704383 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Malignant tumor of urinary bladder, Cerebrooculofacioskeletal syndrome 2 |
| RS866706988 |
SOX9
|
Health Risk |
Pathogenic/Likely pathogenic |
Camptomelic dysplasia, CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL |
| RS866712684 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS866717445 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS866727908 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 4, Autosomal dominant distal renal tubular acidosis |
| RS866728229 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia, Methylmalonic acidemia |
| RS866731784 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS866740147 |
NIPBL
|
Health Risk |
Pathogenic |
De Lange syndrome, De Lange syndrome |
| RS866754647 |
POU3F4
|
Health Risk |
Likely pathogenic |
— |
| RS866756635 |
FMO3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS866763453 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS866769733 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS866769874 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS866771343 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, FAS-related disorder |
| RS866771359 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS866773167 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS866774930 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS866775781 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Squamous cell carcinoma of the head and neck, Li-Fraumeni syndrome |
| RS866783525 |
COL11A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS866785621 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, COL1A1-related disorder |
| RS866789963 |
LRP6
|
Health Risk |
Likely pathogenic |
Tooth agenesis, Tooth agenesis |
| RS866792483 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Immunodeficiency-centromeric instability-facial anomalies syndrome 1 |
| RS866796047 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS866802950 |
PPP1R21
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, facial dysmorphism |
| RS866803539 |
SLC35A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS866804139 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS866809120 |
RPE65
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS866812216 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
Otitis media, susceptibility to |
| RS866814797 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS866815144 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS866815665 |
FOXG1
|
Health Risk |
Conflicting classifications of pathogenicity |
FOXG1 disorder, FOXG1 disorder |
| RS866818044 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS866821968 |
TCIRG1
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS866822473 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Leber congenital amaurosis 8 |
| RS866823474 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS866836744 |
PAX8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism, congenital |
| RS866837129 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS866837583 |
XDH
|
Health Risk |
Pathogenic |
Xanthinuria type II, Xanthinuria type II |
| RS866838115 |
PRRT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS866839234 |
ABCB11
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS866839255 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS866839831 |
RLIM
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS866842287 |
ZNF462
|
Health Risk |
Pathogenic |
Weiss-Kruszka syndrome, ZNF462-related disorder |
| RS866845681 |
MLH1
|
Health Risk |
Pathogenic |
Colorectal cancer, hereditary nonpolyposis |
| RS866846166 |
EFTUD2
|
Health Risk |
Likely pathogenic |
EFTUD2-related disorder, EFTUD2-related disorder |
| RS866852986 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS866856763 |
MYH14
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 4A, Ovarian serous cystadenocarcinoma |
| RS866863840 |
PROM1
|
Health Risk |
Likely pathogenic |
— |
| RS866873846 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS866874156 |
SNIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS866878858 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS866880466 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS866881260 |
KCNJ5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperaldosteronism type III, Familial hyperaldosteronism type III |
| RS866887062 |
FLNC
|
Health Risk |
Likely pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Myofibrillar myopathy 5 |
| RS866892723 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS866895236 |
FIG4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS866898562 |
POGZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS866898746 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS866898949 |
SPOP
|
Health Risk |
Conflicting classifications of pathogenicity |
Prostate cancer, Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies |
| RS866899109 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS866904446 |
PFKM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type VII |
| RS866917013 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS866919041 |
HS6ST2
|
Health Risk |
Pathogenic |
Paganini-Miozzo syndrome, Paganini-Miozzo syndrome |
| RS866921933 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital hyperammonemia |
| RS866922524 |
PTS
|
Health Risk |
Likely pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS866936431 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS866938979 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS866941536 |
ODAPH
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A4, Amelogenesis imperfecta hypomaturation type 2A4 |
| RS866943725 |
AFG2A
|
Health Risk |
Likely pathogenic |
— |
| RS866945292 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal recessive spinocerebellar ataxia 14 |
| RS866946278 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS866948739 |
RINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS866949431 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS866959693 |
HMOX1
|
Health Risk |
Likely pathogenic |
— |
| RS866964055 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS866964603 |
POC1A
|
Health Risk |
Likely pathogenic |
— |
| RS866966373 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS866966651 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS866970619 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS866975469 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS866978361 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS866981753 |
AGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS866982675 |
IQCB1
|
Health Risk |
Pathogenic |
Renal dysplasia and retinal aplasia, Nephronophthisis |
| RS866982998 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS866984082 |
ABCB4
|
Health Risk |
Likely pathogenic |
Cholestasis, intrahepatic |
| RS866987981 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS866991159 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS866993296 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS866994863 |
IGFBP7
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal arterial macroaneurysm with supravascular pulmonic stenosis, Familial retinal arterial macroaneurysm |
| RS866997710 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS866997713 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS867000687 |
UNC80
|
Health Risk |
Likely pathogenic |
— |
| RS867010473 |
CAMK2D
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS867010959 |
LMBRD1
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS867012156 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS867015582 |
CEP63
|
Health Risk |
Likely pathogenic |
— |